Results 1-10 of 55
Publication DateTitleAuthor(s)
31-Mar-2016On the use of propensity scores in case of rare exposureHajage, D; Tubach, F; Steg, PG; Bhatt, DL; De Rycke, Y
2-Jun-2016The MARINER trial of rivaroxaban after hospital discharge for medical patients at high risk of VTE. Design, rationale, and clinical implications.Raskob, GE; Spyropoulos, AC; Zrubek, J; Ageno, W; Albers, G, et al
1-Jul-2016Long-term Tolerability of Ticagrelor for the Secondary Prevention of Major Adverse Cardiovascular Events: A Secondary Analysis of the PEGASUS-TIMI 54 Trial.Bonaca, MP; Bhatt, DL; Oude Ophuis, T; Steg, PG; Storey, R, et al
21-Jun-2016Lipoprotein-Associated Phospholipase A2 Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease.Wallentin, L; Held, C; Armstrong, PW; Cannon, CP; Davies, RY, et al
1-Nov-2012Women and men with stable coronary artery disease have similar clinical outcomes: insights from the international prospective CLARIFY registrySteg, PG; Greenlaw, N; Tardif, J-C; Tendera, M; Ford, I, et al
27-Apr-2015Use of Anticoagulants and Antiplatelet Agents in Stable Outpatients with Coronary Artery Disease and Atrial Fibrillation. International CLARIFY RegistryFauchier, L; Greenlaw, N; Ferrari, R; Ford, I; Fox, KM, et al
3-May-2012Heart Rate and Use of Beta-Blockers in Stable Outpatients with Coronary Artery DiseaseSteg, PG; Ferrari, R; Ford, I; Greenlaw, N; Tardif, J-C, et al
18-Sep-2015Bradycardia and atrial fibrillation in patients with stable CAD treated with Ivabradine: The SIGNIFY StudyFox, KM; Ford, I; Steg, PG; Tardiff, J-C; Tendera, M, et al
10-Sep-2015Cyclosporine before PCI in Patients with Acute Myocardial InfarctionCung, TT; Morel, O; Cayla, G; Rioufol, G; Garcia-Dorado, D, et al
15-Mar-2016Paracetamol, Ibuprofen, and recurrent major cardiovascular and major bleeding events in 19,120 patients with recent ischaemic strokeGonzalez-Valcarcel, J; Sissani, L; Labreuche, J; Bousser, M-G; Chamorro, A, et al